German biotech company BioNTech and U.S. drugmaker Pfizer said they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.

Vanessa Brill, Vice President and Regional General Counsel for Dr. Reddy’s Laboratories operations in the Americas, discusses various topics including what she looks for in outside legal counsels and drug supply chain issues.

According to data published in The New England Journal of Medicine, a Phase I trial of Moderna’s mRNA vaccine against SARS-CoV-2 demonstrated promising safety and immune response in all patients involved in the study.

Novartis AG agreed to pay more than $729 million to settle U.S. government charges that the company paid illegal kickbacks to doctors and patients to boost drug sales, the U.S. Department of Justice said.

A federal judge dismissed a challenge by hospital groups to a federal rule requiring them to disclose prices they quietly negotiate with insurers, in a victory for White House efforts to make healthcare pricing more transparent to patients.

Scientists resumed COVID-19 trials of the now world-famous drug hydroxychloroquine, as confusion continues to reign about the anti-malarial hailed by U.S. President Donald Trump as a potential “game-changer” in fighting the pandemic.

Outcome Health announced the OH Virtual Waiting Room, ushering the Point of Care sector into telemedicine with an empathetic, unique patient experience whenever and wherever patients are meeting with their physicians.

This white paper considers how incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.

Patients given the malaria drug touted by President Donald Trump as a potential treatment for COVID-19 did not improve significantly over those who did not, according to two new studies published in the medical journal BMJ .

FCB Health Network president and CEO Dana Maiman announced the launch of YuzuYello, the network’s specialized group dedicated to helping brands exceed their patients’ expectations and transforming patient experiences.